Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference

    NEXT STORY
    AzurRx BioPharma Presents Positive Secondary Endpoint Data in its Phase II MS1819-SD Chronic Pancreatitis Study at the 2019 Digestive Disease Week Conference
    PREV STORY
    OSE Immunotherapeutics Receives Notice of Allowance for New U.S. Patent Protecting Anti-IL-7 Receptor Antagonist OSE-127
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    KESSLER TOPAZ MELTZER & CHECK, LLP:  Final Deadline Reminder for CHEMBIO DIAGNOSTICS, INC. Investors – CEMI

    author_avatar
    NASDAQ Market News

    Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting of Shareholders

    author_avatar
    NASDAQ Market News

    CytomX Announces Selection by Bristol-Myers Squibb of First Clinical Candidate Probody From Collaboration

    SOUTH SAN FRANCISCO, Calif., Dec. 13, 2016 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

    author_avatar
    NASDAQ Market News